Tracon Pharma: Final Response Assessment Data in All Patients From ENVASARC Phase 2 Pivotal Trial Expected in 3Q
Tracon Pharma: Final Response Assessment Data in All Patients From ENVASARC Phase 2 Pivotal Trial Expected in 3Q
Tracon Pharma：预计将在第三季度公布ENVASARC 2期关键试验中所有患者的最终反应评估数据
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册